KalVista Pharmaceuticals (KALV) Accumulated Depreciation & Amortization: 2014-2024
Historic Accumulated Depreciation & Amortization for KalVista Pharmaceuticals (KALV) over the last 1 years, with Apr 2024 value amounting to $3.7 million.
- KalVista Pharmaceuticals' Accumulated Depreciation & Amortization was N/A to $3.7 million in Q2 2024 from the same period last year, while for Apr 2024 it was $6.5 million, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2024, which is N/A change from last year.
- As of Q2 2024, KalVista Pharmaceuticals' Accumulated Depreciation & Amortization stood at $3.7 million, which was up 171.35% from $1.4 million recorded in Q2 2020.
- KalVista Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $3.7 million for Q2 2024, and its period low was $1.4 million during Q2 2020.
- For the 1-year period, KalVista Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $3.7 million, with its median value being $3.7 million (2024).
- Data for KalVista Pharmaceuticals' Accumulated Depreciation & Amortization shows a peak YoY soared of 52.68% (in 2020) over the last 5 years.
- Over the past 2 years, KalVista Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at $1.4 million in 2020, then followed by $3.7 million in 2024.
- Its last three reported values are $3.7 million in Q2 2024, $1.4 million for Q2 2020, and $896,000 during Q2 2019.